Presentation TCT 2017 Manual Aspiration Thrombectomy in STEMI: Do Any Subgroups Benefit? Presenter: David P. Faxon, Robert S. Schwartz, Stefan K. James October 31, 2017
Presentation TCT 2017 Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold Presenter: Azeem Latib, Gregg W. Stone October 31, 2017
Presentation TCT 2017 Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow Presenter: David P. Faxon, Robert S. Schwartz, Raffaele Piccolo October 31, 2017
Presentation TCT 2017 ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption Presenter: Azeem Latib, Bernard R. Chevalier October 31, 2017
Presentation TCT 2017 Coronary Flow, Collateral Flow, and Fractional Flow Reserve in Culprit and Nonculprit Lesions in STEMI Presenter: David P. Faxon, Robert S. Schwartz, Matthias Götberg October 31, 2017
Presentation TCT 2017 ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings Presenter: Azeem Latib, Manel Sabate October 31, 2017
Presentation TCT 2017 Recognition, Diagnosis, and Management of Spontaneous Coronary Artery Dissection Presenter: David P. Faxon, Robert S. Schwartz, Jacqueline Saw October 31, 2017
Presentation TCT 2017 Femoral Venous Access and Closure Presenter: Stefan C. Bertog, Apostolos Tzikas, Sameer Gafoor October 31, 2017
Presentation TCT 2017 New Insights From AIDA: Subgroups and Predictors of Adverse Events Presenter: Azeem Latib, Joanna J. Wykrzykowska October 31, 2017
News Conference News TCT 2017 Long-term Absorb BVS Data Continue to Disappoint Michael O'Riordan October 31, 2017
Presentation TCT 2017 TCT 99: Safety and Efficacy of Percutaneous Axillary Artery Access for Mechanical Circulatory Support With the Impella© Devices: An Initial Evaluation From the Axillary Access Registry to Monitor Safety (ARMS) MultiCenter Registry Presenter: Vladimir Dzavik, Srihari S. Naidu, James M. McCabe October 31, 2017
News Conference News TCT 2017 DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis Todd Neale October 30, 2017
Presentation TCT 2017 PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results Presenter: Ioannis Iakovou, Gert Richardt, Shigeru Saito October 30, 2017
Presentation TCT 2017 PLLA-Based Biolimus A9 Elution I: Outcomes With the BioMatrix Family of DES Presenter: Ioannis Iakovou, Gert Richardt, Christophe Dubois October 30, 2017
Presentation TCT 2017 The Orsiro Sirolimus-eluting Stent: Outcomes From the BIOFLOW and BIORESORT Trials Presenter: Ioannis Iakovou, Gert Richardt, Clemens von Birgelen October 30, 2017
Presentation TCT 2017 MiStent and DESSOLVE III Outcomes: Are the Stent and Clinical Trial Results Unique? Presenter: Ioannis Iakovou, Gert Richardt, Robert J. de Winter October 30, 2017
Presentation TCT 2017 Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT Presenter: Ioannis Iakovou, Gert Richardt, Dean J. Kereiakes October 30, 2017
Presentation TCT 2017 Pros and Cons of Bioabsorbable Polymer-Based DES: Will They Translate Into Improved Clinical Outcomes Compared to the Best Durable Polymer-Based DES? Presenter: Ioannis Iakovou, Gert Richardt, Renu Virmani October 30, 2017
Presentation TCT 2017 BioNIR: Specifications and BIONICS/NIREUS Results in Perspective Presenter: Stephen G. Ellis, David E. Kandzari October 30, 2017
Presentation TCT 2017 Resolute and Onyx Zotarolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective Presenter: Stephen G. Ellis, David E. Kandzari, Matthew J. Price October 30, 2017